Chip Baird
Chief Executive Officer at 2SEVENTY BIO, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
William Denise Baird is currently the Chief Executive Officer & Director at 2seventy Bio, Inc. He is also the Chairman at Deep Genomics, Inc. Mr. Baird previously served as an Independent Director at Axcella Health, Inc. from 2018 to 2023.
He was also a Director at Amicus Therapeutics UK Ltd.
Mr. Baird held the position of Chief Financial Officer at Amicus Therapeutics, Inc. from 2012 to 2018 and at PTC Therapeutics, Inc. from 2002 to 2012.
He briefly served as the Chief Financial & Accounting Officer at bluebird bio, Inc. in 2021.
Prior to that, Mr. Baird worked as an Engagement Manager at The Lek from 1999 to 2002.
He holds an MBA from The Wharton School of the University of Pennsylvania and an undergraduate degree from the Edmund A.
Walsh School of Foreign Service.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2SEVENTY BIO, INC.
0.60% | 2024-03-31 | 308,585 ( 0.60% ) | 2 M $ | 2024-03-30 |
AXCELLA HEALTH, INC.
-.--% | 2023-10-30 | 0 ( -.--% ) | - $ | 2023-12-30 |
Chip Baird active positions
Companies | Position | Start |
---|---|---|
2SEVENTY BIO, INC. | Chief Executive Officer | - |
Deep Genomics, Inc.
Deep Genomics, Inc. BiotechnologyHealth Technology Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada. | Chairman | 2023-09-14 |
Former positions of Chip Baird
Companies | Position | End |
---|---|---|
AXCA HEALPAR | Director/Board Member | 2023-10-31 |
BLUEBIRD BIO, INC. | Director of Finance/CFO | 2021-11-03 |
AMICUS THERAPEUTICS, INC. | Director of Finance/CFO | 2018-12-18 |
PTC THERAPEUTICS, INC. | Director of Finance/CFO | 2012-03-31 |
The Lek/Alcar Consulting Group, Inc.
The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA. | Corporate Officer/Principal | 2001-12-31 |
Training of Chip Baird
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Edmund A. Walsh School of Foreign Service | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
AMICUS THERAPEUTICS, INC. | Health Technology |
PTC THERAPEUTICS, INC. | Health Technology |
BLUEBIRD BIO, INC. | Health Technology |
AXCA HEALPAR | Health Technology |
2SEVENTY BIO, INC. | Health Technology |
Private companies | 3 |
---|---|
The Lek/Alcar Consulting Group, Inc.
The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA. | Commercial Services |
Deep Genomics, Inc.
Deep Genomics, Inc. BiotechnologyHealth Technology Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada. | Health Technology |
Amicus Therapeutics UK Ltd.
Amicus Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Amicus Therapeutics, Inc., Amicus Therapeutics UK Ltd. is a private company that focuses on delivering high-quality therapies for persons living with rare and orphan diseases. The company is based in Gerrards Cross, UK. The employees of Amicus crafted a belief statement that encompasses their core values and reminds them of the reason they do what they do every day. The statement outlines the fundamental beliefs that are crucial to understanding the passion and commitment behind Amicus. The British company believes in the fight to remain at the forefront of therapies for rare and orphan diseases, supporting the disease communities and their families, and fostering teamwork and respect for each individual's contribution. | Commercial Services |
- Stock Market
- Insiders
- Chip Baird